Core Scientific, Inc./tx (CORZ)
NasdaqGS · Price as of · Nasdaq Real Time Price
- Profitability0/20
Losing money: $-1.43B net income over the last four reported quarters. Revenue over the last four reported quarters was $440.3M, up 27% from $348.0M the year before.
- Insider buying vs selling17/20
Some insider buying (2 buys, $244,352) against larger selling (25 sells, $3.1M). Any open-market buying is worth noticing. Separately, 5 new 5%+ stake disclosures (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings6/15
Share count up 5.2% in a year. Real dilution.
- Analysts16
- Implied upside+115.3%
- Target range$28.00 to $55.00
- EPS expected-$0.04
- A year ago-$0.20
- Revenue expected$192.7M +138%
- Estimate range-$0.05 to -$0.03
CORZ closed at $17.94 on Sep 11, down 14.0% since Aug 12. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is above the 200-day (uptrend structure); trading at 28% of the 52-week range ($13.57 to $29.16).
Insider buying and selling at Core Scientific, Inc./tx (CORZ)
The most recent Form 4 on record for Core Scientific, Inc./tx (CORZ) is August 20, 2026, when Elizabeth Crain, Director, bought $109,994 of stock. An open-market purchase is money the filer chose to put in.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Elizabeth Crain · Director | Buy | $109,994 | August 20, 2026 | Notable buy |
| Eric Stanton Weiss · Director | Buy | $134,358 | August 18, 2026 | Notable buy |
| Todd M Duchene · See remarks | Sell | $200,974 | August 17, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $222,340 | August 3, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $209,476 | July 27, 2026 | Routine |
| Todd M Duchene · See remarks | Sell | $222,995 | July 20, 2026 | Routine |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | September 10, 2026 | FORM 4 |
| 8-K | September 10, 2026 | 8-K |
| 4 | September 2, 2026 | FORM 4 |
| 8-K | August 27, 2026 | 8-K |
| 4 | August 26, 2026 | FORM 4 |
| 4 | August 24, 2026 | FORM 4 |
| 4 | August 20, 2026 | FORM 4 |
| 4 | August 19, 2026 | FORM 4 |
Core Scientific news
All 21 articles
Core Scientific (CORZ) got conditional ERCOT approval for its Texas sites. The final power allocation is still open.
A three-paragraph 8-K puts numbers on the Texas grid question that has hung over Core Scientific since Governor Abbott ordered an audit of data centers in ERCOT's interconnection queue in August.
Leopold Aschenbrenner sold 11.5 million Core Scientific (CORZ) shares below the Aug. 3 low. The stock closed up 10%.
Leopold Aschenbrenner's Situational Awareness sold 11,519,078 Core Scientific (CORZ) shares in two block trades on Aug. 3 at an average near $19.59, both priced under the session low. The stake fell to 4.4% from 8.1%, which ends the reporting obligation. He still holds 14,089,395 shares.
Bitcoin is sliding, and the AI data center miners are sliding with it (IREN, CORZ, CLSK)
A dozen former bitcoin miners now call themselves AI data center companies. With bitcoin down near $58,300 and sliding a second day, most fell with it, while the names furthest from crypto held up best.
Articles that mention Core Scientific without it being the main subject.
JPMorgan double-upgrades IREN Ltd (IREN) as AI slowdown rattles peers
JPMorgan moved IREN two notches to overweight and lifted its target to $65 from $46, hours after co-CEO Daniel Roberts posted a long rebuttal to the calls for an AI slowdown. Every comparable name we checked fell on Monday. IREN did not.
IREN signed a frontier AI lab and is paying 9% to finance the GPUs. Microsoft deployment debt costs 6%.
IREN (IREN) reported fiscal 2026 results and a new multi-year contract with an unnamed leading frontier AI lab. The same release prices its GPU debt by customer: 9.0% on $2.4 billion for non investment grade deployments, 6.0% on the $3.6 billion behind Microsoft.
The SEC subpoenaed four Wall Street banks over the Situational Awareness meltdown, the New York Times reports
Bank of America, Citigroup, Goldman Sachs and JPMorgan Chase were told to preserve records on Leopold Aschenbrenner's fund as regulators examine trade timing and leverage from its near collapse in July.
Frequently asked questions
When does CORZ report earnings?
Core Scientific, Inc./tx (CORZ) is scheduled to report quarterly results on October 23, 2026 (estimated). The 2-analyst consensus is -$0.04 per share on revenue of $192.7M for the quarter ending September 30, 2026, against -$0.20 and $81.1M a year earlier. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for CORZ?
16 analysts cover Core Scientific, Inc./tx (CORZ). The consensus rating is Strong buy. The average price target is $37.13, in a range of $28.00 to $55.00.
Are insiders buying or selling CORZ?
We track Form 4 filings for Core Scientific, Inc./tx (CORZ). The activity listed on this page shows 2 open-market purchases and 4 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see CORZ SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed September 10, 2026.